KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Net Cash Flow (2016 - 2025)

Petmed Express' Net Cash Flow history spans 16 years, with the latest figure at -$9.2 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 372.43% year-over-year to -$9.2 million; the TTM value through Dec 2025 reached -$23.2 million, down 3607.87%, while the annual FY2025 figure was -$576000.0, 98.82% up from the prior year.
  • Net Cash Flow reached -$9.2 million in Q4 2025 per PETS's latest filing, down from -$5.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $12.2 million in Q1 2021 to a low of -$42.6 million in Q2 2023.
  • Average Net Cash Flow over 5 years is -$4.0 million, with a median of -$4.5 million recorded in 2023.
  • Peak YoY movement for Net Cash Flow: skyrocketed 1396.18% in 2021, then tumbled 651.01% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at $2.3 million in 2021, then surged by 150.4% to $5.9 million in 2022, then crashed by 168.53% to -$4.0 million in 2023, then skyrocketed by 51.77% to -$1.9 million in 2024, then tumbled by 372.43% to -$9.2 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Net Cash Flow are -$9.2 million (Q4 2025), -$5.0 million (Q3 2025), and -$13.6 million (Q2 2025).